Yuan Li Shen - Concepedia

Author

Yuan Li Shen

United States Food and Drug Administration ORCID

Also Known As

Y Shen, Y. Shen, Ya-ting Shen, Yanchi Shen, Yuan L Shen, Yuan Li Shen, Yuan Shen, Yuan-Li Shen, Yuan-li Shen, Yuan‐Li Shen

137

Publications

4.6K

Citations

H-Index

113

Concepts

All Affiliations

United States Food and Drug Administration Center for Drug Evaluation and Research Xi'an Jiaotong University First Affiliated Hospital of Xi'an Jiaotong University Fred Hutch Cancer Center

About

Yuan Li Shen is an author at United States Food and Drug Administration specializing in medicine, public health, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	878
2	Public Health	8	8	228
3	Health Sciences	4	4	502
4	Management	1	1	10
5	Social Sciences	1	1	96

Yuan Li Shen

Publications

Citations

H-Index

Page 1

	Year	Citations
FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme Martin H. Cohen, Yuan Li Shen, Patricia Keegan, The Oncologist	2009	635
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia Aviva C. Krauss, Xin Gao, Liang Li, Clinical Cancer Research	2018	315
Loss of Function of the Melanocortin 2 Receptor Accessory Protein 2 Is Associated with Mammalian Obesity Masato Asai, Shwetha Ramachandrappa, Maria Joachim, Science Melanocortin 2Mc4r SignalingInsulin SignalingGastrointestinal Peptide HormoneObesity	2013	294
FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma Yvette L. Kasamon, R. Angelo de Claro, Yaping Wang, The Oncologist	2017	189
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma Sandra J. Casak, Martha Donoghue, Lola A. Fashoyin‐Aje, Clinical Cancer Research	2020	170
FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal Carcinoma Sandra J. Casak, Leigh Marcus, Lola A. Fashoyin‐Aje, Clinical Cancer Research	2021	167
Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial Hao Lai, Yunfeng Li, Yafang He, Gut Microbes	2023	160
FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation Kelly J. Norsworthy, Lola Luo, Vicky Hsu, Clinical Cancer Research Differentiation SyndromeMixed-phenotype Acute LeukemiaPharmacotherapyTransfusion DependenceMyeloid Neoplasia	2019	133
FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease Emily Y. Jen, Qing Xu, Aaron J. Schetter, Clinical Cancer Research	2018	124
FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia Kelly J. Norsworthy, Kunthel By, Sriram Subramaniam, Clinical Cancer Research	2019	118

Page 1